These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 27779459)
1. Vascular effects of the lercanidipine/enalapril combination: clinical relevance. Parati G Curr Med Res Opin; 2016 Oct; 32(sup2):25-28. PubMed ID: 27779459 [TBL] [Abstract][Full Text] [Related]
2. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Antza C; Stabouli S; Kotsis V Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Ghiadoni L; Bruno RM; Cartoni G; Stea F; Magagna A; Virdis A; Grassi D; Ferri C; Taddei S Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528 [TBL] [Abstract][Full Text] [Related]
4. Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis. Rizzoni D Curr Med Res Opin; 2016 Oct; 32(sup2):17-23. PubMed ID: 27779458 [TBL] [Abstract][Full Text] [Related]
5. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension. De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890 [TBL] [Abstract][Full Text] [Related]
6. Fixed-dose combination lercanidipine/enalapril. Hair PI; Scott LJ; Perry CM Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666 [TBL] [Abstract][Full Text] [Related]
7. Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis. Rizzoni D Curr Med Res Opin; 2016 Oct; 32(sup2):13-15. PubMed ID: 27779457 [TBL] [Abstract][Full Text] [Related]
8. Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Robles NR; Calvo C; Sobrino J; Espinel E; Esteban R; Mateos L; Macias JF Curr Med Res Opin; 2016 Oct; 32(sup2):29-34. PubMed ID: 27779460 [TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study. De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779 [TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387 [TBL] [Abstract][Full Text] [Related]
11. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril. Barrios V; Escobar C; Echarri R Vasc Health Risk Manag; 2008; 4(4):847-53. PubMed ID: 19066001 [TBL] [Abstract][Full Text] [Related]
12. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y; J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects. Tsioufis K; Tsioufis C; Dimitriadis K; Mantzouranis E; Mani I; Tousoulis D Curr Med Res Opin; 2016 Oct; 32(sup2):35-41. PubMed ID: 27779461 [TBL] [Abstract][Full Text] [Related]
14. Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study. Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P J Am Soc Hypertens; 2014 Jun; 8(6):422-8. PubMed ID: 24836352 [TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999 [TBL] [Abstract][Full Text] [Related]
16. Role of the fixed-dose combination lercanidipine-enalapril in renal protection. Egan CG; Pontremoli R J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study. Arnaout S; Curr Med Res Opin; 2015 Jan; 31(1):187-90. PubMed ID: 25424779 [TBL] [Abstract][Full Text] [Related]
19. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Burnier M; Pruijm M; Wuerzner G Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal. Maldonado J; Pereira T; Tavares A Drugs R D; 2014 Jun; 14(2):147-54. PubMed ID: 24831818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]